from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3050c/-

LFCtreatmentdescriptionclass of inhibitor

-0.169

Amikacinug/mL Amikacintranslation

0.793

Cap5-10ug/mL Capreomycintranslation

0.604

Rox10-50 ug/mL Roxithromycintranslation

1.668

SM2-5 ug/mL Streptomycintranslation

-0.581

Tet5-10 ug/mL Tetracyclinetranslation

-1.813

Rif0.2-5ug/mL Rifampicintranscription

-0.997

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.098

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.165

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.509

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.519

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.551

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.280

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.081

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.285

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.434

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.411

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.081

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.105

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.569

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.489

KCN5-20 ug/mL Potassium cyaniderespiration

-0.145

NaN30.2-2 mM Sodium aziderespiration

0.127

Nigericin50 uM Nigericinrespiration

-1.036

TRC10-150 ug/mL Triclosanrespiration

-1.737

TRZ10-25 ug/mL Thioridazinerespiration

0.845

Valinomycin0.5-10 uM Valinomycinrespiration

0.087

ZnSO42 mM ZnSO4respiration

1.466

menadione6-10 ug/mL Menadionerespiration

-0.016

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.225

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.050

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.239

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.858

NRP_1Non-replicating persistence stage 1dosRassociated

0.646

Amp0.2mg/mL AmpicillincellWall

0.205

Cephalexin20-100 ug/mL CephalexincellWall

0.436

Cerulenin0.32-5 ug/mL CerulenincellWall

0.076

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.127

EMB10-20 ug/mL EthambutolcellWall

-0.293

Eta12-40 ug/mL EthionamidecellWall

-0.438

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.554

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.646

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.005

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.437

BZA0.12 mg/mL BenzamidearomaticAmides

0.663

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.585

H2O24 mM hydrogen peroxideDNAdamaging

0.414

Levo10 ug/mL LevofloxacinDNAdamaging

0.144

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.134

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.145

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.195

UVUV-irradiationDNAdamaging

1.212

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.276

Antimycin12.5-50 ug/mL Antimycin A?

0.146

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.023

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.080

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.687

PA8240.2-2 ug/mL PA-824?

1.111

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.315

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.172

Verapamil50 uM Verapamil?

0.240

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.024

methoxatin10-20 ug/mL Methoxatin?